A Kamagate, S Qu, G Perdomo, D Su, DH Kim … - The Journal of Clinical Investigation, 2008 - pubmedcentral.nih.gov Excessive production of triglyceride-rich VLDL is attributable to
hypertriglyceridemia. VLDL production is facilitated by microsomal triglyceride
transfer protein (MTP) in a rate-limiting step that is regulated by ... Cited by 16 - Related articles - BL Direct - All 7 versions
G Musso, R Gambino, M Cassader - Progress in Lipid Research, 2009 - Elsevier Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease in Western countries and is considered the hepatic manifestation of
metabolic syndrome. The hallmark of NAFLD is hepatic neutral lipid ... Cited by 7 - Related articles - All 2 versions
S Kakizaki, Y Yamazaki, D Takizawa, M … - Current Drug Metabolism, 2008 - ingentaconnect.com Abstract: The xenobiotic receptors CAR and PXR constitute two important members
of the NR1I nuclear receptor family. They function as sensors of toxic
byproducts derived from the endogenous metabolism and of exogenous ... Cited by 7 - Related articles - All 2 versions
J Capeau - Diabetes and Metabolism, 2008 - Elsevier Insulin resistance is commonly found in a large number of adults—in
particular, those with android obesity, the metabolic syndrome or type 2
diabetes. Strong adverse relationships between adipose tissue, liver and ... Cited by 4 - Related articles - All 3 versions
R Menghini, S Menini, R Amoruso, L Fiorentino … - Gastroenterology, 2009 - Elsevier Obesity-driven, low-grade inflammation affects systemic metabolic function and
can lead to insulin resistance, hepatic steatosis, and atherosclerosis.
Decreased expression of tissue inhibitor of metalloproteinase 3 (Timp3) is ... Cited by 4 - Related articles - All 3 versions
A Kamagate, HH Dong - Cell cycle (Georgetown, Tex.), 2008 - pubmedcentral.nih.gov Very low-density lipoproteins (VLDL) are triglyceride-rich particles. VLDL is
synthesized in hepatocytes and secreted from the liver in a pathway that is
tightly regulated by insulin. Hepatic VLDL production is stimulated in ... Cited by 3 - Related articles - All 4 versions
L Valenti, A Ludovica Fracanzani, S Fargion - Seminars in Immunopathology, 2009 - Springer Abstract Alcoholic liver disease and nonalcoholic liver disease represent a
leading cause of liver disease and share similar pathogenic mechanisms among
which activation of the immune system plays a key role. The main events ... Cited by 1 - Related articles - All 2 versions
M Malaguarnera, M Di Rosa, F Nicoletti, L … - Journal of Molecular Medicine, 2009 - Springer Abstract Non-alcoholic fatty liver disease (NAFLD) is an emerging
metabolic-related disorder characterized by fatty infiltration of the liver in
the absence of alcohol consump- tion. NAFLD ranges from simple steatosis to ... Cited by 2 - Related articles - All 2 versions
[CITATION] 45 Non-alcoholic Fatty Liver Disease: A Pathophysiological Perspective
AL Fracanzani, L Valenti, S Fargion - Hepatology - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
